Brief: Catalyst Pharmaceuticals FY Revenue USD 491.7 Million Vs. IBES Estimate USD 484.1 Million

Catalyst Pharmaceuticals

26/02/2025 21:14

Feb 26 (Reuters) - Catalyst Pharmaceuticals FY net income USD 163.9 million.

FY operating income USD 195.1 million vs. IBES estimate USD 183.8 million

FY adjusted net income USD 81.5 million vs. IBES estimate USD 167.9 million

outlook FY revenue USD 545-565 million